Gerd Geißlinger

Also affiliated with Fraunhofer Institute for Translational Medicine and Pharmacology

MedicineBiochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and PharmaceuticsNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?”.

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?

Frontiers in Pharmacology(2022)10.3389/fphar.2022.838782

N/A

0DataRank · unranked

188 citations

Hartmut Kühn, Astrid S. Kahnt, Katharina M. Rund, Valerie B. O’Donnell, Nicolas Flamand +13 more

The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors

British Journal of Pharmacology(2024)10.1111/bph.17366

N/A

0DataRank · unranked

11 citations

Beatrice Pflüger‐Müller, Virna Margarita Martín Giménez, Fiona Sailer, Henrik Dirks, Simonida Zehr +21 more